You have 9 free searches left this month | for more free features.

small lymphocytic lymphoma.

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • (no location specified)
Nov 22, 2023

Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

Not yet recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 10, 2023

Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

Recruiting
  • Relapsed or Refractory CD19+ B-cell Lymphoma
  • +2 more
  • TBI-2001
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 26, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +5 more
  • (no location specified)
Jul 21, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2022

Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance

Not yet recruiting
  • Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
    • (no location specified)
    Dec 16, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • TQB3909 tablet
    • Zhengzhou, Henan, China
    • +1 more
    Jul 17, 2023

    Orelabrutinib in the Treatment of CLL/SLL

    Not yet recruiting
    • CLL/SLL
      • (no location specified)
      Jul 26, 2023

      Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

      Active, not recruiting
      • Recurrent Chronic Lymphocytic Leukemia
      • +3 more
      • Duarte, California
      • +2 more
      Oct 7, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Boston (pyrimethamine)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Leukemia
      • Boston, Massachusetts
      • +1 more
      Nov 14, 2022

      Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • +5 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 12, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Scottsdale, Jacksonville, Rochester (drug, other, biological)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Scottsdale, Arizona
      • +2 more
      Jan 5, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Duarte (procedure, biological, drug)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Biospecimen Collection
      • +4 more
      • Duarte, California
        City of Hope Medical Center
      Jan 30, 2023

      Leukemia, Lymphoma Trial in Houston (Rituximab, Lenalidomide)

      Active, not recruiting
      • Leukemia
      • Lymphoma
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Oct 11, 2022

      Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell Trial in Whittier (Pirtobrutinib, Ibrutinib)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • +3 more
      • Whittier, California
        Innovative Clinical Research Institute
      Aug 8, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Leukemia
      • (no location specified)
      Nov 30, 2022

      Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

      Not yet recruiting
      • Relapsed Non-Hodgkin Lymphoma
      • +6 more
      • (no location specified)
      Apr 12, 2023

      Chronic Lymphocytic Leukemia, Richter Syndrome, Small Lymphocytic Lymphoma Trial in Rochester (Acalabrutinib, Durvalumab,

      Recruiting
      • Chronic Lymphocytic Leukemia
      • +2 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 4, 2023

      Small Lymphocytic Lymphoma, CLL (Chronic Lymphocytic Leukemia) Trial run by the National Heart, Lung, and Blood Institute

      Active, not recruiting
      • Small Lymphocytic Lymphoma
      • CLL (Chronic Lymphocytic Leukemia)
      • Fludarabine Phosphate
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Oct 13, 2022

      Newly Diagnosed Asymptomatic High-Risk Chronic Lymphocytic

      Recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • EQ-5D-5L Instrument
      • +2 more
      • Vancouver, British Columbia, Canada
      • +3 more
      Dec 12, 2022

      Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

      Completed
      • Lymphoid Leukemia
      • +2 more
      • Madison, Wisconsin
        University of Wisconsin
      Jan 30, 2023

      B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

      Not yet recruiting
      • B-cell Malignancy
      • +7 more
      • (no location specified)
      Oct 26, 2022

      Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Ibrutinib 420 mg)

      Not yet recruiting
      • Autoimmune Hemolytic Anemia
      • +3 more
      • Ibrutinib 420 mg
      • (no location specified)
      Jan 12, 2023

      (CHANT)Real World Study of Duvelisib in Treatment of

      Not yet recruiting
      • Follicular Lymphoma
      • +5 more
      • (no location specified)
      Jun 20, 2023